426
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Effects of Fenofibric Acid on Diabetic Macular Edema: The MacuFen study

, , , &
Pages 307-317 | Received 25 Nov 2013, Accepted 31 May 2014, Published online: 18 Aug 2014
 

Abstract

Purpose: Fenofibrate reduced progression of diabetic retinopathy in two large randomized studies. The effect of 135 mg fenofibric acid on diabetic macular edema (DME) was evaluated in subjects with existing DME.

Methods: In this double-blind, randomized, placebo-controlled study, 110 subjects with DME not requiring immediate photocoagulation or intraocular treatment with adequate diabetes and blood pressure control received either fenofibric acid or placebo once daily for 1 year. Total macula volume (TMV) and thickness were measured in the worse eye and all eligible eyes with time-domain optical coherence tomography at baseline and quarterly thereafter.

Results: TMV decreased by −0.35 mm3 (within-group difference) after fenofibric acid treatment and by −0.11 mm3 after placebo. The between-group comparison of the change was −0.25 mm3 (95% confidence interval, CI, −0.645–0.155; p = 0.227, worse eye analysis). Weighted inner zone thickness and volume decreased by −18.7 µm and −0.13 mm3, respectively, for within group difference after fenofibric acid and by −3.1 µm and −0.02 mm3, respectively, after placebo. Considering all eligible eyes, thicknesses at central zone, mean inner zone, and entire retina decreased by −21.3 µm, −19.8 µm, and −20.4 µm, respectively, after fenofibric acid. No between-group difference in changes of these measurements was observed. Triglycerides decreased by 23% after fenofibric acid (vs 4% after placebo, p = 0.001) and high-density lipoprotein cholesterol increased by 8% (vs 0.3%, p = 0.014). No safety concern was identified.

Conclusion: Subjects treated with fenofibric acid had a modest improvement in TMV, although the study was probably underpowered to detect a benefit over placebo after 1 year.

Acknowledgments

We thank all subjects for their participation in the study, all investigators, and site staff for their valuable contributions and support in the study conduct. Christelle Foucher is acknowledged for her contribution in writing the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.